Rituximab Plus Avacopan Increases Remission Rates in ANCA-Associated Vasculitis
Anisha Dua, MD, MPH Credit: American College of Rheumatology Convergence Patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) treated with rituximab (RTX) showed a significant increase in remission sustained at …